The association of ventral tegmental area histopathology with adult dementia.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Archives of Neurology

• Publication date

  1988-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1988.00520290025008PMID 3358699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.

  1987cited by this paper
• Pathologic correlates of dementia in Parkinson's disease.

  1986cited by this paper
• Lewy Body Dementia Without Alzheimer Changes

  1986cited by this paper
• MPTP: current concepts and controversies.

  1986cited by this paper
• Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease

  1986cited by this paper
• Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: Distribution of enzyme activities and some behavioral implications

  1986cited by this paper
• Mesolimbocortical dementia. A clinicopathologic case study of a putative disorder.

  1986cited by this paper
• An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease.

  1986cited by this paper
• Perforant pathway changes and the memory impairment of Alzheimer's disease

  1986cited by this paper
• Parkinson's disease

  1985cited by this paper
• Dementia without Alzheimer pathology

  1985cited by this paper
• Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat.

  1985cited by this paper
• Nucleus Raphe Dorsalis in Dementia of the Alzheimer Type: Neurofibrillary Changes and Neuronal Packing Density

  1984cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.

  1983cited by this paper
• Drug-induced Parkinsonism and idiopathic Parkinson's disease.

  1983cited by this paper
• A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.

  1983cited by this paper
• Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.

  1980cited by this paper
• Is the mesocortical dopaminergic system involved in Parkinson disease?

  1980cited by this paper
• Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey.

  1979cited by this paper
• Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase.

  1979cited by this paper
• Kindling of the mesolimbic dopamine system

  1978cited by this paper
• Central catecholamine neuron systems: anatomy and physiology of the dopamine systems.

  1978cited by this paper
• Topographic organization of the projections from the entorhinal area to the hippocampal formation of the rat

  1976cited by this paper
• The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine‐B‐hydroxylase as a marker

  1975cited by this paper
• Limbic dementia1

  1973cited by this paper
• Cytoarchitecture of the substantia nigra in the rat.

  1970cited by this paper
• THE EFFECT OF EXERCISE ON THE VASCULAR BED OF SKELETAL MUSCLE.

  1964cited by this paper
• EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

  1964cited by this paper

• Dopamine D3 Receptors: A Potential Target to Treat Motivational Deficits in Parkinson's Disease.

  2022cites this paper
• Malattia di Parkinson e depressione

  2019cites this paper
• Pathologic role of nitrergic neurotransmission in mood disorders.

  2019cites this paper
• Neuropsychiatric aspects of Parkinson disease psychopharmacology: Insights from circuit dynamics.

  2019cites this paper
• Maladie de Parkinson et dépression

  2019cites this paper
• Depressive symptoms in schizophrenia patients: A possible relationship between SIRT1 and BDNF.

  2019cites this paper
• The dopamine system, Parkinson's disease and language function

  2018cites this paper
• The pathophysiological mechanisms of motivational deficits in Parkinson's disease

  2018cites this paper
• Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease.

  2018cites this paper
• Factors associated with depression in patients with Parkinson’s disease A multicenter study in Lima, Peru

  2018cites this paper
• A comprehensive overview of the neuropsychiatry of Parkinson's disease: A review.

  2017cites this paper
• 4 Neuropsychological Functions and SPECT Neuroimaging in Parkinson ’ s Disease

  2017cites this paper
• Association of low serum BDNF with depression in patients with Parkinson's disease.

  2017cites this paper
• Olfactory impairment in Parkinson’s disease is a consequence of central nervous system decline

  2017cites this paper
• The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

  2016cites this paper
• Motivational Deficits in Parkinson’s Disease: Role of the Dopaminergic System and Deep-Brain Stimulation of the Subthalamic Nucleus

  2016cites this paper
• On historical consciousness: A pilot investigation

  2016cites this paper
• Alexithymia in Parkinson's disease: A systematic review of the literature.

  2016cites this paper
• Are SSRIs responsible for precipitating suicidal ideation in teenagers with 'subsyndromal' bipolar affective disorder who have been misdiagnosed with unipolar depression?

  2016cites this paper
• Mesolimbic dopaminergic dysfunction in Parkinson’s disease depression: evidence from a 123I-FP-CIT SPECT investigation

  2015cites this paper
• The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up

  2015cites this paper
• Mesocortical dopaminergic dysfunction in Parkinson's disease-depression: Evidence from a 123I-FP-CIT SPECT investigation

  2013cites this paper
• 17 Cognitive and Behavioural Changes After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson ’ s Disease

  2012cites this paper
• Cognitive and Behavioural Changes After Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease

  2012cites this paper
• Brain amyloid and cognition in Lewy body diseases

  2012cites this paper
• Développement d'un modèle animal chez le rat reproduisant un déficit motivationnel pouvant s'apparenter à un syndrome d'apathie de la maladie de Parkinson

  2012cites this paper
• Cortical-Limbic-Striatal Dysfunction in Depression Converging Findings in Basal Ganglia Diseases and Primary Affective Disorders

  2012cites this paper
• Frontostriatal Cognitive Staging in Parkinson's Disease

  2012cites this paper
• Is depression in Parkinson's disease (PD) a specific entity?

  2012cites this paper
• Frontostriatal Cognitive Staging in Parkinson's Disease

  2011cites this paper
• Depression in Parkinson disease—epidemiology, mechanisms and management

  2011cites this paper
• Neuropsychological Functions and SPECT Neuroimaging in Parkinson’s Disease

  2011cites this paper
• Anatomy and Physiology of Limbic System Dysfunction in Parkinson's Disease

  2011cites this paper
• Emotional Dysfunction in Parkinson’s Disease

  2011cites this paper
• The relationship between depression and regional cerebral blood flow in Parkinson’s disease and the effect of selegiline treatment

  2011cites this paper
• Expanding the Model of Apathy in Parkinson's Disease: Exploration of Conceptual Domains and Identification of Neuropsychological Correlates

  2011cites this paper
• Regional variation in mitochondrial DNA copy number in mouse brain.

  2011cites this paper
• Neurocircuitry of Mood Disorders

  2010cites this paper
• Pragmatic comprehension deficit in Parkinson's disease

  2010cites this paper
• Intensity-dependent facial emotion recognition and cognitive functions in Parkinson’s disease

  2010cites this paper
• Personality Science: Three Approaches and Their Applications to the Causes and Treatment of Depression

  2010cites this paper
• Pathology of Parkinson's Disease

  2010cites this paper
• Pathologic Correlates of Dementia in Individuals with Lewy Body Disease

  2010cites this paper
• Neuropsychiatry of Parkinson's disease.

  2009influential citation
• Cognitive impairment and dementia in patients with Parkinson disease.

  2009cites this paper
• Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

  2009cites this paper
• The role of dopamine in bipolar disorder.

  2009cites this paper
• 精神疾患の死後脳研究の歴史，現状，今後の展望

  2009cites this paper
• Neuropsychiatric symptoms in Parkinson's disease

  2009cites this paper
• I disturbi neuropsicologici nella malattia di Parkinson

  2009cites this paper
• Characterizing the relation between depressive symptoms and Parkinson's disease in a sample of Swedish twins

  2009cites this paper
• Die Rolle der dopaminergen Degeneration in VTA und SNc in der Entwicklung depressiven Verhaltens im Tiermodell

  2008cites this paper
• Are Psychiatric Disorders a Risk for the Development of Neurological Disorders

  2008cites this paper
• Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?

  2008cites this paper
• Nonmotor manifestations of Parkinson's disease

  2008cites this paper
• Error related negativity in Parkinson's disease: A test of the validity of mesencephalic dopamine contributions to ERN

  2008cites this paper
• The Neuro-Behavioural Syndrome of Brainstem Disease

  2008cites this paper
• The influence of anxiety and depression on cognitive functioning in Parkinson's disease

  2008cites this paper
• Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study.

  2007cites this paper
• The impact of depressive symptoms in early Parkinson disease

  2007cites this paper
• The Effects of Acute Tryptophan Depletion on Movement, Mood, and Cognition in Patients with Parkinson’s Disease and Healthy Older Persons

  2007cites this paper
• Transtornos depressivos na doença de Parkinson de início precoce

  2007cites this paper
• Demenz und Depression bei Patienten mit idiopathischem Parkinson-Syndrom

  2007cites this paper
• Depression predicts the pattern of cognitive impairment in early Parkinson's disease.

  2006cites this paper
• Alexithymia in Parkinson's disease is related to severity of depressive symptoms

  2006cites this paper
• Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease

  2006cites this paper
• Early onset parkinsonism in dementia lacking distinct histopathological features.

  2006cites this paper
• The effect of depression on motor function and disease severity of Parkinson's disease.

  2006cites this paper
• Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection.

  2006cites this paper
• Cognitive, affective, and psychiatric features of Parkinson's disease.

  2006cites this paper
• Treatment of depression in Parkinson’s disease

  2006cites this paper
• Are dementia and depression in Parkinson's disease related?

  2006cites this paper
• Clinical phenotype of Parkinson disease dementia

  2006cites this paper
• Depression in Parkinson's disease – a review

  2006cites this paper
• Cognitive Change in Parkinson Disease

  2006cites this paper
• Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease

  2005cites this paper
• The Brain and Behavior: Basal ganglia

  2005cites this paper
• Affektive Symptome beim Morbus Parkinson und atypischen Parkinson-Syndromen

  2005cites this paper
• Correlates of excessive daytime sleepiness in Parkinson's disease.

  2005cites this paper
• Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

  2005cites this paper
• The Brain and Behavior by David L. Clark

  2005cites this paper
• PET/SPECT characterization of cognitive deficits in Parkinson's disease

  2004cites this paper
• Psychiatric Disorders in Parkinsonian Syndromes-Nuclear Medicine Contribution

  2004cites this paper
• Relation of “Sense Of Self” to Executive Function Performance in Parkinson's Disease

  2003cites this paper
• Cognitive and Emotional Dysfunction after Central Pontine Myelinolysis

  2003cites this paper
• Nonmotor symptoms of Parkinson’s disease

  2003cites this paper
• Cortical-Limbic-Striatal Dysfunction in Depression

  2003cites this paper
• Counterfactual cognitive deficit in persons with Parkinson’s disease

  2003cites this paper
• A note on hiccups

  2003cites this paper
• Beyond the iron mask: Towards better recognition and treatment of depression associated with Parkinson's disease

  2002cites this paper
• Depression in Parkinson's disease.

  2002cites this paper
• 73 NEUROCIRCUITRY OF MOOD DISORDERS

  2002cites this paper
• Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.

  2002cites this paper
• Dopaminergic syndromes of sleep, mood and mentation: Evidence from Parkinson's disease and related disorders

  2002cites this paper
• Neuropathological changes underlying neuropsychiatric symptoms in Alzheimer’s disease

  2002cites this paper
• Clinical features and comorbidity of mood fluctuations in Parkinson's disease.

  2002cites this paper
• Dopaminergic Impairment Is Related to Cortical Dysfunction in Parkinson’s Disease

  2002cites this paper
• Psychiatric aspects of Parkinson's disease

  2002cites this paper
• Deafferentation‐induced abnormal neurofilament phosphorylation in red nucleus neurones

  2001cites this paper
• Neuroimaging in basal ganglia disorders: Perspectives for transcranial ultrasound

  2001cites this paper